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Shigella spp. are the causative agent of bacillary dysentery. Infection results in acute colonic injury due to the
host inflammatory response. The mediators of the damage, infiltrating polymorphonuclear leukocytes (PMN),
also resolve the infection. Shigella flexneri’s virulence effectors are encoded on its large virulence plasmid and
on pathogenicity islands in the chromosome. The SHI-2 pathogenicity island encodes the virulence factor ShiA,
which down-regulates Shigella-induced inflammation. In the rabbit ileal loop model, infection with a shiA null
strain (shiA) induces a more severe inflammation than wild-type infection. Conversely, a Shigella strain that
overexpresses ShiA (ShiA) is less inflammatory than the wild-type strain. To determine the host responses
modulated by ShiA, we performed infection studies using the mouse lung model, which recapitulates the
phenotypes observed in the rabbit ileal loop model. Significantly, ShiA strain-infected mice cleared the
bacteria and survived infection, while wild-type- and shiA strain-infected mice could not clear the bacteria
and ultimately died. Surprisingly, microarray analysis of infected lungs revealed the regulation of genes
involved in innate T-cell responses to infection. Immunohistochemistry showed that wild-type- and shiA
strain-infected animals have greater numbers of PMN and T cells in their lungs over the course of infection
than ShiA strain-infected animals. These results suggest that the T-cell innate response is suppressed by ShiA
in Shigella infections.
Shigella flexneri is a causative agent of bacillary dysentery,
infecting approximately 165 million people per year worldwide.
Children under 5 years of age represent 61% of the 1.1 million
annual deaths (19, 50). Shigella infection provokes a highly
inflammatory response in the colon of the host. Symptoms of
shigellosis can range from a mild diarrhea to bloody, mucopu-
rulent stools (36).
Upon ingestion of contaminated food or water, Shigella uses
specialized antigen-sampling cells, called M cells, to cross the
colonic epithelial barrier (33, 41, 48). The bacteria are then
taken up by the underlying resident macrophages (16, 42),
where they escape from the phagosome into the cytoplasm (9,
23). Once there, the bacteria secrete the virulence factor IpaB
(invasion plasmid antigen B), which activates caspase-1 (5, 43),
leading to cytotoxicity. Concomitant to caspase-1-induced cell
death, interleukin-1 (IL-1) and IL-18 are released (12, 13).
Subsequently, Shigella invades the basolateral side of intestinal
epithelial cells (27), resulting in the release of IL-8 (38). To-
gether, IL-1, IL-18, and IL-8 initiate a proinflammatory cas-
cade that recruits polymorphonuclear leukocytes (PMN) (35,
37, 38). PMN migrate to the colon and cross the epithelial cell
barrier to the lumen. Crossing this barrier disrupts the epithe-
lial cell tight junctions and provides Shigella additional access
to the tissue. Thus, the infection is initially exacerbated by the
PMN (34). The PMN are, however, crucial for resolution of
infection because they kill Shigella (22) and eradicate the in-
fection. Shigella spp. manipulate host innate immunity by in-
ducing inflammation via cytokines to enhance their infectivity;
however, it is this host innate response that ultimately clears
the bacteria.
The proinflammatory response to Shigella is induced by the
delivery of bacterial effector proteins through the type 3 secre-
tion system. Shigella invasion and cytotoxicity genes, such as
ipaB, are encoded on a large virulence plasmid. Plasmid-cured
strains are not pathogenic (40). However, while the large vir-
ulence plasmid is necessary for infection, several chromosomal
loci are required for a full inflammatory response (8, 39). One
of these chromosomal loci contains the Shigella pathogenicity
island SHI-2, a region that encodes several cryptic mobility
genes, an aerobactin operon, and seven novel open reading
frames (26, 47).
ShiA, a product of one of the novel open reading frames in
SHI-2, is a suppressor of inflammation (14). A strain disrupted
in shiA (shiA) induces more severe inflammation character-
ized by an exacerbated PMN influx in the rabbit ileal loop
model. Conversely, a strain overexpressing ShiA (ShiA) pro-
voked very little inflammation and PMN recruitment com-
pared to wild-type infection. Interestingly, ShiA is not involved
in Shigella invasion, cytotoxicity, or cytokine regulation in vitro.
This suggests that ShiA affects a previously unknown Shigella
virulence mechanism.
In this study, we investigate the mechanism by which ShiA
regulates inflammation in the mouse lung model of infection
(45, 46). This model recapitulates the acute inflammation seen
in natural infections and allows us to investigate survival and
kinetics of infection using the many tools available for the mouse.
We first demonstrate that the phenotypes of wild-type Shigella,
shiA, and ShiA strain infections in the mouse model are
similar to those seen in the rabbit model, and we then use
microarray, real-time PCR, and enzyme-linked immunosor-
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bent assay (ELISA) analyses to investigate differences in gene
and protein expression during lung infections. We find that
many proinflammatory genes are expressed at higher levels in
wild-type or shiA strain infection than in ShiA strain infec-
tion. Interestingly, a subset of these gene products either re-
cruits or is secreted from T cells. Furthermore, we observe that
there are significantly more T cells at the site of wild-type and
shiA strain infection than at the site of ShiA strain infection.
A role for T cells in the innate immune response to Shigella
infection was recently suggested by Le-Barillec et al. (20). Our
results suggest that in S. flexneri infections, ShiA down-regu-
lates an innate inflammatory response that includes the re-
cruitment of T cells.
MATERIALS AND METHODS
Bacterial strains and growth conditions. Wild-type S. flexneri strain M90T (40)
contains the empty pUC19 vector. The shiA strain contains a chloramphenicol
cassette inserted into shiA (26) and the empty pUC19 vector, and the Shi
strain is M90T carrying a pUC19 plasmid encoding shiA (14). Shigella strains
were grown at 37°C in tryptic soy broth or on Luria broth plates containing
ampicillin (100 g/ml) when appropriate.
Immunoblot. Cultures of wild-type Shigella, ShiA, and shiA strains grown
overnight were subcultured for 3 h, and bacterial equivalents, as determined by
optical density (OD) measurement, were subjected to sodium dodecyl sulfate-
polyacrylamide gel electrophoresis and analyzed by immunoblot with a poly-
clonal mouse anti-ShiA antibody and a polyclonal rabbit anti-RecA antibody.
Mouse infections. All experimental protocols were approved by the Institu-
tional Animal Care and Use Committee. Mice were housed in filter-top cages
and provided with sterile water and food ad libitum. C57BL/6 mice were ob-
tained from Charles River Laboratories (Wilmington, MA, or Sulzfeld, Ger-
many), from Elevage Janvier (Le Genest Saint Isle, France), or from the
Bundesinstitut fu¨r Risikobewertung (Berlin, Germany). Within an experiment,
all mice came from the same source. Mouse experiments were performed as
previously described (45). Briefly, mice were anesthetized by intramuscular in-
jection of ketamine (12 mg/ml; Ketavet Pharmacia, Erlangen, Germany) and
xylazine (4 mg/ml; Rompun Bayer, Leverkusen, Germany) in phosphate-buffered
saline (PBS). Bacterial strains were resuspended in PBS and inoculated intra-
nasally in a single application of 20 l (inoculum of 2  107 to 5  107
CFU/mouse in each experiment, with all mice receiving the same inoculum
within a single experiment, as determined by OD measurement and dilution
plating of the inoculum). At different time points, mice were sacrificed, and the
lungs were removed and processed for bacterial CFU enumeration, cytokine
analysis, histology, or RNA isolation.
Lungs were homogenized in 1 ml of PBS, diluted, and plated onto the appro-
priate antibiotic agar plates for CFU enumeration. Homogenized lungs were
then microcentrifuged at top speed for 5 min, and the supernatants were used for
cytokine analysis. Murine IL-17 and IL-6 ELISAs were obtained from R&D
Systems (Minneapolis, MN). For histology, lungs were fixed in 4% paraformal-
dehyde and embedded in paraffin for further processing as described below. For
RNA isolation, lungs were homogenized in 1 ml TRIzol (Invitrogen, Carlsbad,
CA) solution and frozen for future processing.
Immunohistochemistry of mouse lung sections. Paraffin sections were pro-
cessed using standard techniques. For LPS and terminal deoxynucleotidyltrans-
ferase-mediated dUTP-biotin nick end labeling, sections were digested with 20
g/ml proteinase K for 6 min at room temperature. Blocking buffer included goat
normal immune serum, fish gelatin, bovine serum albumin, and Tween 20.
Primary antibody was applied overnight at 4°C (for LPS staining, 1:40 dilution of
rabbit S. flexneri serotype 5 anti-LPS [Accurate Chemical & Scientific Corp.,
Westbury NY]; for PMN staining, 1:200 dilution of anti-PMN-specific membrane
protein [MCA771G; Serotec]; for T-cell staining, 1:200 dilution of rabbit anti-
human anti-CD3 [Dako, Carpinteria, CA]). Secondary antibody was applied for
2 h at 37° (goat anti-rabbit immunoglobulin G [IgG] [Cy3 conjugated], goat
anti-rabbit IgG [Cy2 conjugated], and goat anti-rat IgG [Cy2] [Jackson Immu-
noresearch Europe, Cambridgeshire, United Kingdom]). Hoechst dye was
used to visualize nuclei. Sections were analyzed using ImageJ (http://rsb.info
.nih.gov/ij/).
Microarrays. Briefly, RNA was purified from homogenized lung samples with
the RNeasy Clean Up kit (QIAGEN, Hilden, Germany) and quality controlled
using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA). RNA
amplification, direct labeling, hybridization, and slide scanning were carried out
by Icoria (Research Triangle Park, NC). All samples were hybridized to mouse
custom microarrays purchased from Agilent Technologies. The arrays were de-
signed in concert between the Max Planck Institute for Infection Biology and
Agilent Technologies. The design includes genes relevant for innate and adaptive
immunity as well as unique coding sequences from several organs (e.g., lung,
intestine, spleen, liver, and stomach).
Microarray scans were first subjected to Agilent Technologies image analysis
software (G2567AA Feature Extraction software [version A6.1.1.1]). All subse-
quent analyses were carried out using the Rosetta Resolver gene expression data
analysis system, version 4.0 (Rosetta Inpharmatics, Seattle, WA). Expression
patterns were identified by a stringent analysis using twofold expression change
and error-weighted cutoffs using a P value of 0.05.
Real-time PCR. RNA samples were treated with DNase (Invitrogen, Carlsbad,
CA) before cDNA synthesis. Reverse transcription was performed according to
the manufacturer’s instructions using random primers (Superscript III reverse
transcriptase and Random Primers; Invitrogen, Carlsbad, CA). Real-time PCR
was performed using SYBR Green PCR Master Mix (Applied Biosystems,
Darmstadt, Germany) in an ABI Prism 7000 sequence detection system PCR
machine (Applied Biosystems, Darmstadt, Germany). Data were normalized to
glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The primers used in
this study are as follows: GAPDH forward, CATGGCCTTCCGTGTTCCT;
GAPDH reverse, GCGGCACGTCAGATCCA; IL-17 forward, CCCTTGGC
GCAAAAGTGA; IL-17 reverse, CGTGGAACGGTTGAGGTAGTCT; IL-6
forward, ACCACGGCCTTCCCTACTTC; IL-6 reverse, TTGGGAGTGGT
ATCCTCTGTGAA; IL-1 forward, CTGGTGTGTGACGTTCCCATT;
IL-1 reverse, CGACAGCACGAGGCTTTTTT; Scyb2/macrophage inflam-
matory protein 2 (MIP-2) forward, CCTCAACGGAAGAACCAAAGAG;
Scyb2/MIP-2 reverse, AGGCACATCAGGTACGATCCA; Scya2/monocyte
chemoattractant protein 1 (MCP-1) forward, GGCTCAGCCAGATGCAGT
TAA; Scya2/MCP-1 reverse, CCTACTCATTGGGATCATCTTGCT; GRO-
1/keratinocyte-derived protein chemokine (KC) forward, CCTCAAGAACA
TCCAGAGCTTGA; growth-regulated oncogene 1 (GRO-1)/KC reverse, AG
TGTGGCTATGACTTCGGTTTG.
Relative quantitation of gene expression was calculated using the comparative
cycle threshold method. This method is outlined in the ABI User Bulletins (http:
//dna-9.int-med.uiowa.edu/RealtimePCRdocs/Compar_Anal_Bulletin2.pd).
RESULTS
ShiA strain-infected mice survive infection. Our previous
study established that ShiA down-regulates the host inflamma-
tory response to infection (14). To further characterize the
regulation of inflammation mediated by ShiA, we used the
mouse lung model of infection. The mouse lung model reca-
pitulates many of the inflammatory characteristics of intestinal
Shigella infection (45) while giving us more avenues of study
than are possible in the rabbit model. To determine the effect
of ShiA on survival of infected animals, we inoculated anes-
thetized C57BL/6 wild-type mice intranasally with bacteria. We
compared three strains (described in Materials and Methods):
(i) a wild-type Shigella strain (40), (ii) the hyperinflammatory
shiA strain (14), and (iii) the hypoinflammatory ShiA strain
(14). These three strains are isogenic, with the exception of
their level of ShiA expression. Immunoblot experiments con-
firmed that the shiA strain does not expresses ShiA while the
ShiA strain overexpresses ShiA in comparison to expression
in the wild-type strain (Fig. 1A).
Six hours postinfection, all mice had ruffled fur and a
stooped posture, indicating sickness. Wild-type- and shiA
strain-infected animals appeared moribund until time of death.
In contrast, ShiA strain-infected animals appeared healthy as
early as 10 h postinfection and were very active for the dura-
tion of the experiment. There was no difference in the survival
of animals infected with wild-type Shigella or shiA strains
(Fig. 1B). Both infections resulted in death on or before day 3.
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In contrast, ShiA strain-infected mice survived until the ter-
mination of the experiment.
ShiA strain-infected mice clear their bacterial load. To
determine if the differences in survival depended on bacterial
clearance, we assessed the number of bacteria in the lung. Mice
were infected with wild-type bacteria or shiA or ShiA strains
and sacrificed at 6, 24, 48, and 72 h. At 6 h, all mice had similar
bacterial loads, regardless of the infecting strain, demonstrat-
ing that all strains can establish infection equally well (Fig. 2).
This result correlated with our observations using the rabbit
model (14). Bacterial counts in mice infected with wild-type
Shigella or shiA strains increased dramatically (1.5 logs) be-
tween 6 h and 24 h and then began to decrease only at 48 h
(Fig. 2, blue [wild type] and red [shiA] symbols). Similar to
the survival experiments, all wild-type- and shiA strain-in-
fected animals died by 72 h. In contrast, in a ShiA strain
infection, the number of CFU decreased by more than 2 logs
from 6 h to 72 h (Fig. 2, green symbols). At 24 h, there was a
further 2 log difference in bacterial counts between ShiA
strain infected animals and either wild-type- or shiA strain-
infected animals. This difference increased to greater than 3
logs at 48 h. Differences between ShiA and wild-type strain
CFU and ShiA and shiA strain CFU are statistically signif-
icant at 24 h (wild type, P  0.001; shiA strain, P  0.0006)
and 48 h (P  0.0006, both comparisons). The CFU data
correlate with the survival data where wild-type- and shiA
strain-infected animals have high bacterial counts in their lungs
and die while the ShiA strain-infected animals clear the in-
fection and survive.
To determine the distribution of the bacterial load in in-
fected animals, mice were infected with wild-type Shigella,
shiA, or ShiA strains and sacrificed at 6, 10, 24, and 48 h.
Mouse lungs were immunostained with S. flexneri serotype
5-specific anti-LPS antibody. In all infections, very few bacteria
could be seen at 6 h (Fig. 3A, E, and I). This is due to the low
CFU relative to lung volume. Beginning at 10 h, wild-type and
shiA strain infections showed bacteria localized as both indi-
vidual cells and aggregates in the lung (Fig. 3B to D and F to
H). The aggregates were most apparent at 24 h (Fig. 3C and G)
and decreased slightly at 48 h (Fig. 3D and H) in these two
infections. These data correlate with the large increase and
FIG. 1. ShiA strain-infected mice survive infection. (A) Cultures
of wild-type Shigella, ShiA, and shiA strains grown overnight were
subcultured for 3 h, and bacterial equivalents, as determined by OD
measurement, were subjected to sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis and analyzed by immunoblot with a poly-
clonal mouse anti-ShiA antibody. In the top panel, the top band is
ShiA, while the second band (*) is an unrelated protein that cross-
reacts with the antibody. The bottom panel is immunoblotted with a
polyclonal rabbit anti-RecA antibody used as a loading control.
(B) Mice were infected with the wild type (WT) or the shiA or ShiA
strain (n  20 mice/group). Only ShiA strain-infected mice survived
the infection (green line). Wild-type- and shiA strain-infected ani-
mals succumbed to infection with the same kinetics (blue and red lines,
respectively). An  denotes a statistical difference in survival between
ShiA strain infection and wild-type or shiA strain infection (P 
0.007 using the log-rank test). Similar results were obtained from two
independent experiments.
FIG. 2. Only the ShiA strain is cleared from the lungs of infected mice. Mice were infected with the wild type (WT) or the shiA or ShiA
strain (n  7 mice/group). To determine bacterial load, infected mouse lungs were homogenized and plated for CFU at the indicated times. A †
indicates dead wild-type- and shiA strain-infected mice at 72 h. An  denotes that ShiA strain CFU are statistically different from CFU from
wild-type infection (P  0.001) and shiA strain infection at 24 h (P  0.0006). A # denotes that ShiA strain CFU are statistically different from
CFU from wild-type infection and shiA strain infection at 48 h (P  0.0006). Statistics were determined by Mann-Whitney nonparametric test.
Similar results were obtained from three independent experiments with 7 to 10 mice per group.
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subsequent decrease in CFU at 24 and 48 h, respectively, in
these infections (Fig. 2). In ShiA strain-infected tissue, we
never observed bacterial aggregates (Fig. 3I to L), correlating
with the lower CFU throughout this infection (Fig. 2).
ShiA decreases inflammation in the lung. To determine the
degree of inflammation in each infection, we infected mice
with wild-type Shigella, shiA, and ShiA strains. Animals
were sacrificed at 6, 10, 24, and 48 h, and lungs were stained
with hematoxylin and eosin. As expected, wild-type infection
resulted in a strong inflammatory infiltrate and thickening of
the alveolar walls at 6 and 10 h postinfection (Fig. 4A and B).
At the 24-h time point, lungs presented a severe PMN infiltra-
tion with edema (Fig. 4C). Interestingly, inflammation de-
creased slightly at 48 h (Fig. 4D), and lungs showed signs of
resolution. shiA strain infection provoked the strongest in-
flammatory response (Fig. 4E to H). As early as 6 h, the lungs
showed pronounced PMN infiltration and significant edema
(Fig. 4E). The inflammatory infiltrate and edema increased
over time, and the lung architecture was completely altered
(Fig. 4E to H). As in wild-type infection, infection with the
shiA strain showed a slight decrease in the severity of inflam-
mation at 48 h (Fig. 4H). The decrease in inflammation seen in
the histology at 48 h in wild-type and shiA strain infection
correlates with the decrease in bacterial counts in these same
infections at 48 h (Fig. 2). In contrast, ShiA strain infection
induced very mild inflammation in the mouse lung over time
(Fig. 4I to L). Lungs remained mostly clear and structurally
intact, with only a few infiltrating PMN throughout the dura-
tion of the experiment.
Most significantly, at the 6-h time point, the amount of
inflammation was different (Fig. 4A, E, and I) while the num-
ber of bacteria was the same in each infection (Fig. 2). Inten-
sity of inflammation increased from minimal in the ShiA
strain infection to moderate in the wild-type infection to severe
in the shiA strain infection. This observation suggests that it
is the presence and amount of ShiA, early in infection, that
determine the severity of inflammation in infection, rather
than the bacterial load.
First, these data demonstrate that the ShiA strain is hy-
poinflammatory and that the shiA strain is hyperinflamma-
tory compared to wild-type infection in the mouse lung model,
thereby corroborating our findings in the rabbit ileal loop
model of infection that ShiA can down-regulate inflammation
during infection. Second, these data demonstrate that ShiA
exerts its effects early in infection to repress inflammation
pathways, as differences in inflammation are observed as soon
as 6 h postinfection.
Microarray analysis suggests that T cells are present in a
Shigella infection. Having determined the ShiA-associated
phenotypes in the mouse model, we used microarray analysis
of gene transcription to elucidate the host responses that are
altered by ShiA during infection. The microarrays consisted of
FIG. 3. ShiA strain-infected mice carry a reduced bacterial load in the lungs. Mice were infected with (A to D) wild-type (WT), (E to H)
shiA, and (I to L) ShiA strains. To visualize bacteria, infected lungs were removed at specified times and immunostained with an anti-LPS
antibody specific for Shigella LPS serotype 5 (green). DNA was counterstained with Hoechst dye (blue). Similar results were obtained with
duplicate lungs from two independent experiments.
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8,014 sequences of cytokines, receptors, and other components
of the immune response; unique coding sequences (expressed
sequence tags); and housekeeping controls. We compared
wild-type Shigella infection to ShiA strain infection using
these custom-designed mouse microarrays. We chose to com-
pare infections with these strains because the differences be-
tween wild-type and ShiA strain infection (survival, CFU, and
histology) show greater contrast than those between wild-type
and shiA strain infections in the same assays. To exclusively
identify genes differently regulated between the two infections,
we chose comparative microarrays. With this technique, two
samples are simultaneously applied to the same array, elimi-
nating all genes that are regulated in the same manner during
the two infections from our analysis.
In two independent experiments, we infected mice with wild-
type Shigella or the ShiA strain and sacrificed animals at 6
and 10 h. At these time points, wild-type and ShiA strain
infections showed histological differences, suggesting that ShiA
had already acted to down-regulate inflammation mechanisms.
We generated samples by pooling three mouse lung homoge-
nates from the same time point, strain infection, and experi-
ment. RNA was purified, amplified, labeled, and hybridized to
the arrays as described in Materials and Methods. Each hy-
bridization included equal amounts of differently labeled RNA
from ShiA strain- and wild-type-infected lungs, resulting in a
two-color array. All microarray data presented here are the
ratio of wild-type infection to ShiA strain infection, where a
positive number indicates a greater abundance of signal in the
wild-type infection than in the ShiA strain infection under the
same conditions.
Using stringent analysis criteria (defined in Materials and
Methods), we identified 27 genes at 6 h and 28 genes at 10 h
that were differently regulated during infection (see Table S1
in the supplemental material). The total number of genes reg-
ulated at the two time points is greater than 46 because some
genes showed regulation at both time points. We grouped
significant genes, or genes that had an absolute change greater
than twofold and a P value of less than 0.05, into the following
categories: (i) inflammatory genes, with a subset having T-cell-
associated function, and (ii) genes with functions that have not
yet been implicated in inflammation. The identification of
proinflammatory genes in these infections was expected. Shi-
gella induces very strong inflammation in the host (36). How-
ever, some genes that we identified suggested that ShiA might
down-regulate a T-cell-associated proinflammatory response.
We inferred the presence of T cells based on the abundant
expression of the T-cell-associated cytokines in wild-type in-
fection compared to ShiA strain infection. Microarray anal-
ysis of whole organs is not sensitive to changes in small
amounts of RNA or to changes in RNA from very small cell
populations. Therefore, we interpreted the presence of T-cell
cytokines to mean that either there was a great abundance of
these cytokines being produced by T cells or there was a large
number of T cells at the site of infection. Included in our data
set are IL-17, secreted exclusively from T cells; IL-6 and
MIP-2, which can be secreted from T cells and recruit PMN
FIG. 4. ShiA attenuates Shigella-induced inflammation in the mouse lung. Mice were infected with (A to D) wild-type (WT), (E to H) shiA,
or (I to L) ShiA strains. To visualize inflammation, infected lungs were removed at specified times and hematoxylin and eosin stained. Similar
results were obtained with duplicate lungs from two independent experiments.
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(24, 25, 28); and T-cell and PMN recruitment cytokines such as
MIP-2, MCP-1, and interferon gamma-inducible 10-kDa pro-
tein (IP-10) (2, 4, 6, 24, 25, 29) (more information about this
data set, including additional annotation and relevant litera-
ture citations, can be found in Table S1 in the supplemental
material).
These data suggest that T cells may play an early, innate role
in the response to Shigella infection. The fact that all of these
genes are less abundantly expressed during ShiA strain infec-
tion suggests that ShiA may directly or indirectly dampen the
T-cell response to infection.
Proinflammatory T-cell-associated effectors are more abun-
dant in wild-type and shiA strain infections. We validated the
microarray data and quantified the levels of expression using
real-time PCR for samples from animals infected with wild-
type Shigella, ShiA, and shiA strains. We tested the expres-
sion of IL-17, IL-6, MCP-1, IL-1, MIP-2, and KC. MIP-2 and
KC are mouse orthologs of human IL-8. Relative quantitation
of gene expression was calculated with the comparative cycle
threshold method using GAPDH for normalization.
In two independent experiments, we infected mice with wild-
type Shigella or the shiA or ShiA strain and sacrificed ani-
mals at 6, 10, and 24 h. cDNA was generated from total RNA
pooled from three mice per group for each condition. At 6 h,
IL-17 was induced 20-fold and 12-fold in wild-type- and shiA
strain-infected tissues, respectively, over ShiA strain-infected
tissue (Fig. 5A). At 10 h, IL-17 increased 16-fold and 27-fold in
wild-type- and shiA strain-infected samples, respectively, over
ShiA strain-infected samples. IL-17 levels dropped at 24 h to
five- and sixfold in wild-type and shiA strain infections, respec-
tively, over ShiA strain infection levels. In ShiA strain infec-
tions, IL-17 remained at background, uninfected levels at all time
points (Fig. 5A). IL-6 expression displayed a profile similar to that
of IL-17 (Fig. 5A). At 6 h, IL-6 showed a substantial increase in
induction (25-fold for the wild type and 18-fold for the shiA
strain) over ShiA strain-infected tissue levels (Fig. 5 A). IL-6
dropped approximately threefold at 10 and 24 h in wild-type and
shiA strain infections, compared to the 6-h level, although the
expression level remained higher than that with ShiA infec-
tion at all times (Fig. 5A). In tissues infected with the ShiA
strain, IL-6 remained at background, uninfected levels at all
time points. Other proinflammatory cytokines such as MCP-1,
IL-1, MIP-2, and KC followed a similar trend but at lower
levels of induction (Fig. 5 B). Similar to IL-17 and IL-6, the
level of transcription of each cytokine tested was greater in
tissues infected with wild-type Shigella and shiA strains than
in tissues infected with the ShiA strain (Fig. 5B). For all
cytokines tested, the levels of transcription in ShiA strain-
infected tissues was near the expression levels of uninfected
tissue (Fig. 5A and B).
To show conclusively that mRNA expression levels were
reflective of the amount of protein in infection, we confirmed
protein expression in vivo by ELISA of IL-6. We infected mice
with wild-type Shigella or the shiA or ShiA strain and sac-
rificed animals at 6, 24, and 48 h. At 6 h, IL-6 concentrations
were 12,000 pg in wild-type- and shiA strain-infected lungs
(Fig. 5 C). Wild-type- and shiA strain-infected tissue IL-6
levels maintained consistently high protein levels at 24 and
48 h. In contrast, in the ShiA strain-infected tissue, the IL-6
protein concentration peaked at 6 h at 6,000 pg, half that of
wild-type and shiA strain IL-6 levels. The IL-6 concentration
decreased in ShiA strain-infected tissue at 24 h (1,900 pg) and
48 h (2,600 pg). In uninfected tissue, IL-6 concentrations were
at the limit of detection. IL-6 protein levels in ShiA strain
FIG. 5. Wild-type- and shiA strain-infected animals have in-
creased levels of IL-17 and IL-6 mRNA. (A and B) Mice were infected
with wild-type (wt), shiA, and ShiA strains (n  3 mice/group). To
assess gene transcription levels, lungs were removed at 6, 10, and 24 h,
homogenized in TRIzol, and pooled, and total RNA was extracted.
RNA was reverse transcribed to cDNA, which served as the template
for real-time PCR for (A) IL-17 and IL-6 and (B) IL-1, MCP-1,
MIP-2, and KC expression. Uninfected controls represent six mice.
Similar results were obtained with triplicate lungs from two indepen-
dent experiments. (C) Mice were infected with wild-type, shiA, and
ShiA strains (n  4 mice/group). To assess IL-6 protein levels, lungs
were removed at 6, 24, and 48 h and homogenized in PBS. Superna-
tants from homogenized lungs served as the sample for IL-6 ELISA.
IL-6 levels from uninfected mouse lungs were at the limit of detection
and are therefore not displayed on the graph.  denotes a statistically
significant difference from wild-type or shiA strain infection (P 
0.05).  denotes a statistically significant difference from wild-type or
shiA strain infection (P  0.005). Statistics were determined by un-
paired t test. Similar results were obtained from three experiments.
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infection are statistically different from wild-type and shiA
strain infection levels at 6 h (P 0.05) and at 24 and 48 h (P 
0.005).
Overall, microarray, real-time PCR, and ELISA analyses
show a similar pattern of regulation for the cytokines we
tested. The cellular sources of these cytokines include macro-
phages, fibroblasts, and epithelial, endothelial, and T cells,
suggesting that ShiA induces a global down-regulation of in-
flammatory signals early in infection. Of particular note, we
observed suppression of T-cell-associated cytokines during
ShiA strain infection, suggesting both the presence of T cells
during the acute phase of wild-type Shigella infection and that
ShiA inflammatory down-regulation includes suppression of
T-cell-regulated inflammation.
PMN infiltration and T-cell number increase in wild-type
and shiA strain infections. Our microarray and real-time
PCR data indicated that cytokines relevant to PMN recruit-
ment were elevated in wild-type and shiA infections and were
expressed only at background, uninfected levels in ShiA
strain infections. IL-17, IL-6, MIP-2, and KC induce PMN
maturation and migration (18, 21, 44). In addition, to date, one
study has addressed the involvement of T cells in the innate
immune response to Shigella infection (20). Our expression
data indicated that T-cell-associated cytokines are elevated in
FIG. 6. ShiA suppresses PMN infiltration into the lungs. Mice were infected with (A to D) wild-type (WT), (E to H) shiA, and (I to L) ShiA
strains. To visualize PMN, infected lungs were removed at specified times and immunostained with an antibody to a PMN surface marker (green).
DNA was counterstained with Hoechst dye (blue). Uninfected controls showed no signal for PMN staining. Tissue section images (6 sections/
condition) from mouse lungs infected for the indicated times were digitized and assessed for intensity of staining (arbitrary units) using ImageJ
1.33A.  denotes a statistically significant difference from wild-type infection (P 0.001); # denotes a statistically significant difference from shiA
strain infection (P  0.001); § denotes a statistically significant difference from shiA strain infection (P  0.05). Statistics were determined by
unpaired t test. Similar results were obtained from two independent experiments.
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wild-type and shiA strain infections. We reasoned that the
high expression level of these cytokines observed in wild-type
and shiA strain infections would result in greater numbers of
PMN and T cells at the site of infection. The converse would
also apply, where PMN influx into ShiA strain-infected tis-
sues should be less than that in a wild-type infection, and fewer
T cells would be present. Therefore, we examined infected
tissue to evaluate the impact of the cytokine expression levels
on PMN and T-cell numbers at the site of infection.
In two independent experiments, we infected mice with wild-
type Shigella or the shiA or ShiA strain and sacrificed ani-
mals at 6, 10, 24, and 48 h. Representative lung sections were
stained with an antibody recognizing a PMN surface protein
(Fig. 6) or an antibody against CD3, a pan-T-cell marker (Fig. 7).
To quantify the amount of PMN migration or the number of T
cells in the infected tissue, we digitized randomly selected
stained sections from each time point and infection and as-
sessed the overall level of intensity of the staining. Intensity is
expressed as an arbitrary number, and the values from six
sections from each infection and time point are represented in
Fig. 6 (PMN) and Fig. 7 (T cells).
As expected, uninfected mouse lungs did not contain PMN
(Fig. 6). In infected lungs, PMN infiltrated shortly after infec-
tion (6 h) with all strains (Fig. 6A, E, and I). In both wild-type
and shiA strain infections, there was greater PMN infiltration
over time than in ShiA strain infection (Fig. 6A to D and E
FIG. 7. ShiA suppresses the T-cell-number increase in the lungs. Mice were infected with (A to D) wild-type (WT), (E to H) shiA, and (I to
L) ShiA strains. To visualize T cells, infected lungs were removed at specified times and immunostained with anti-CD3, a pan-T-cell marker
(orange). DNA was counterstained with Hoechst dye (blue). Uninfected controls reveal the resident T-cell population. Tissue section images
(6 sections/condition) from mouse lungs infected for the indicated times were digitized and assessed for intensity of staining (arbitrary units) using
ImageJ 1.33A.  and  denote a statistically significant difference from wild-type infection (P  0.05; P  0.005); # denotes a statistically
significant difference from shiA strain infection (P  0.001); § denotes a statistically significant difference from shiA infection (P  0.05).
Statistics were determined by unpaired t test. Similar results were obtained from two independent experiments.
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to H, respectively). These data confirm that ShiA is a suppres-
sor of inflammation. The number of PMN remained at a con-
stant high level in wild-type-infected tissues (Fig. 6A to D,
graph). In shiA strain-infected tissues, PMN infiltration in-
creased steadily over the course of infection until 48 h, at which
point it decreased (Fig. 6E to H, graph). The level of infiltra-
tion in shiA strain-infected tissues was greater than that for
the wild type at all time points, although significantly so only at
10 and 24 h (P  0.05). Over the course of ShiA infection,
very few PMN migrated into the tissue (Fig. 6I to L), and the
level of PMN migration was statistically different from that of
wild-type or shiA strain infection (P  0.001) at all time
points. PMN infiltration correlates with the overall amount of
inflammation seen in these three infections (Fig. 4).
In contrast to the PMN staining, but not unexpectedly, un-
infected mouse lung sections had resident intraepithelial T
cells (Fig. 7) (11). In wild-type and shiA strain infections, the
number of T cells was greater than that in ShiA infections as
early as 6 h and increased in infected tissue over time (Fig. 7A
to D and E to H, respectively). The number of T cells was
greatest in tissues infected with the shiA strain and is statis-
tically different from that found in wild-type infection at 10 and
24 h (P 0.05). The number of T cells in ShiA strain-infected
tissue remained similar to that of uninfected tissue at all time
points (Fig. 7I to L) and is statistically different from that
found with a wild-type or shiA strain infection (P  0.05 for
the wild type at 6 and 10 h; P  0.005 for the wild type at 24
and 48 h; P  0.001 for shiA at 6, 10, 24, and 48 h). These
results correlate with the increase in induction of IL-17 mRNA
observed in the microarrays (see Table S1 in the supplemental
material) and real-time PCR (Fig. 5A and B) in wild-type
infection. Conversely, the lack of IL-17 in ShiA strain infec-
tion can be explained by the near lack of T cells in infected
tissues. These results suggest that T cells could play a role in
the innate immune response to Shigella infection and that the
number of T cells in an infection is dependent on the amount
of ShiA present. The number of T cells correlates with the
amount of inflammation induced in infection, suggesting that
the T cells positively influence inflammation.
DISCUSSION
ShiA induces global repression of inflammation. ShiA has a
profound effect on inflammation in Shigella infections. Using
the rabbit ileal loop model, we showed that ShiA down-regu-
lates inflammation. This down-regulation is independent of
phenotypes encoded in the virulence plasmid, since invasion
and cytotoxicity were not affected in shiA mutants (14). Anal-
ogously, in the mouse lung model, infection with the ShiA
strain causes less tissue damage (Fig. 4), lower levels of proin-
flammatory cytokine expression (Fig. 5), and less PMN (Fig. 6)
and T-cell (Fig. 7) accumulation than in wild-type infections.
Accordingly, infection with the shiA strain provokes more
tissue damage (Fig. 4) and an increased number of PMN (Fig.
6) and T cells (Fig. 7) at the site of infection. These data
indicate that both PMN and T-cell influx are down-regulated
by ShiA. Whether ShiA affects the influx of these cells directly
cannot be determined by this study. Importantly, though, the
amount of ShiA, rather than the number of bacteria, directly
regulates this mechanism (Fig. 1A). At 6 h postinfection, tis-
sues infected by all strains carried similar bacterial loads (Fig.
2) but presented differences in inflammation (Fig. 4) as well as
PMN (Fig. 6) and T-cell (Fig. 7) accumulation.
We used microarray analysis to determine which host genes
were modulated by ShiA. Proinflammatory cytokines such as
IL-6, IL-17, MCP-1, IL-1, MIP-2, and KC were expressed at
lower levels in ShiA strain infection than in wild-type infec-
tion (see Table S1 in the supplemental material). Indeed, real-
time PCR showed similar cytokine expression levels in ShiA
strain-infected tissue and uninfected tissue (Fig. 5A and B).
Accordingly, ELISA (Fig. 5C) analysis showed that there was
less IL-6 in ShiA strain infections than in wild-type or shiA
strain infections. Correlating with the lower cytokine expression,
there were fewer PMN (Fig. 6) and T cells (Fig. 7) in ShiA
strain-infected tissues. Finally, we observed that ShiA sup-
presses inflammation as early as 6 h, suggesting that ShiA acts
early in infection.
Different cells, including monocytes, macrophages, fibro-
blasts, and epithelial, endothelial, and T cells, can make the
cytokines we tested. This suggests that the cellular target of
ShiA is likely to be upstream of the activation of these cell
types. Hence, ShiA probably does not directly affect PMN or T
cells, since IL-6, a cytokine expressed by many cell types, is
almost absent from ShiA strain-infected tissues (Fig. 5A).
This suggests that IL-6 is repressed before either PMN or T
cells are involved. Furthermore, IL-1 expression, a cytokine
released by macrophages (Fig. 5B; see Table S1 in the supple-
mental material), is regulated by ShiA, suggesting a suppres-
sion mechanism upstream of macrophage activation. In vitro
infection of epithelial cells, macrophages, and PMN with the
ShiA strain or wild-type Shigella results in similar cytokine
release (data not shown), suggesting that ShiA acts on another
cell type or on an unidentified mediator. The direct effect of
ShiA on inflammation remains to be elucidated. Our microar-
ray analysis showed the regulation of genes either with un-
known function or not thought to be involved in inflammation.
One or more of these genes may be a critical player in the early
initiation of inflammation by ShiA and are under investigation.
We proposed that ShiA evolved to achieve an optimal level
of inflammation. So why is the ShiA strain cleared from
infected lungs in the absence of a significant PMN infiltrate?
Shigella can only invade the basolateral side of the epithelium
(27). The amplification of Shigella invasion depends on the
disruption of the epithelium by PMN transmigration allowing
greater access to the basolateral surface (33). We speculate
that in ShiA strain infections, the suppression of inflamma-
tion and the decrease in PMN influx result in less disruption of
the epithelium, and hence, the infection is not amplified. It is
possible that resident phagocytes and the few recruited PMN
are sufficient to clear the bacteria.
T cells play a role in the immune response to Shigella. Inflam-
mation in Shigella infections was thought to be initiated by mac-
rophages and epithelial cells through IL-1, IL-18, and IL-8. In
this study, we show that T cells may also be involved in the innate
immune response to Shigella infection.
T cells play a key role in the regulation of adaptive immu-
nity. More recently, however, T cells have also been implicated
in initiating innate inflammatory responses (7, 10). In patients
infected with Shigella, specific T-cell subsets are significantly
increased in the lamina propria compared to uninfected indi-
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viduals (15). It is likely that this response is induced by acti-
vated macrophages and dendritic cells, as they can stimulate T
cells to produce IL-17 in vitro (1, 32). IL-17 activates many cell
types, including fibroblasts and epithelial and endothelial cells
(51), to express tumor necrosis factor alpha, IL-1, IL-8, KC,
MIP-2, and other CC and CXC chemokines (3, 17, 18, 31, 52).
These cytokines also stimulate PMN migration (49). We ob-
served an increase in the number of T cells at the site of
infection (Fig. 7) and detected increased levels of IL-17 and
other T-cell cytokines in infected tissues (Fig. 5; see Table S1
in the supplemental material). The role of T cells in Shigella
infections is also supported by the study of Le-Barillec et al.
(20), who demonstrated that mice lacking T, B, and NK cells
(RAG-2 and common 	-chain-deficient RAG2/	c mice) are
more susceptible to infection. The phenotype is restored when
the mice are reconstituted with 
 T cells (20). Taken to-
gether, these data indicate that T cells help regulate the innate
immune response in Shigella infections.
What is the role of T cells in Shigella pathogenesis? We hy-
pothesize that resident dendritic cells and macrophages recruit T
cells early in infection. In turn, these T cells regulate PMN re-
cruitment to the infection site. Dendritic cells sample antigens
directly from the lumen of the intestine (30), and macrophages
capture invading Shigella cells as they traverse M cells (33, 41,
48). Therefore, these cells are likely to be the first cells to
encounter Shigella. We propose that activated dendritic cells
and macrophages then stimulate T cells to produce cytokines
such as IL-17 and IL-6. These cytokines would then act syner-
gistically with IL-1, IL-18, and IL-8 to recruit PMN to the site
of infection. Our hypothesis is in agreement with the data
described previously by Le-Barillec et al. (20). They demon-
strate that in the absence of T cells, mice succumb to Shigella
infection at day 4, compared to controls that survive the infec-
tion. PMN are abundant, however, at the site of infection,
suggesting that T cells are necessary for defense against infec-
tion but that PMN recruitment is independent of T-cell func-
tion. Le-Barillec and colleagues evaluated PMN recruitment
only at day 4, late in infection. It would be of interest to test
whether there is a difference in PMN recruitment early in
infection in the system described previously by Le-Barillec et
al. It is possible that the timely recruitment of PMN, perhaps
by T cells, is essential for survival. We observed an increase in
T cells and PMN as early as 6 h postinfection. Alternatively,
PMN recruitment may not be dependent on T cells, and the
PMN deficiency observed during ShiA strain infection may
be due to the repression of inflammatory signals from epithe-
lial cells and macrophages. However, it is clear from the study
described previously by Le-Barillec et al. and our study that T
cells are required for an adequate innate immune response to
Shigella infections. A comprehensive study to assess the kinet-
ics of the influx of PMN and T cells would determine the role
of T cells in Shigella infection as well as the consequences of
PMN influx in the absence of T-cell cytokine signaling.
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